Related Experiment Videos
Double-balloon instillation device for second-trimester abortion. Outcome in 340 consecutive cases
H Abramovici1, J Bornstein, Y Ben-David
1Department of Obstetrics and Gynecology, Carmel Medical Center, Haifa, Israel.
The Journal of Reproductive Medicine
|January 1, 1995
Summary
A double-balloon device for extraovular prostaglandin instillation achieved a 91% success rate for midtrimester pregnancy termination. This method demonstrated safety and efficacy, even in women with prior cesarean sections.
Area of Science:
- Reproductive Medicine
- Obstetrics and Gynecology
Background:
- Midtrimester pregnancy termination is a critical aspect of reproductive healthcare.
- Traditional methods may carry risks and complications.
Purpose of the Study:
- To evaluate the efficacy and safety of a double-balloon device for extraovular prostaglandin instillation in midtrimester pregnancy termination.
Main Methods:
- Utilized a double-balloon device for extraovular instillation of prostaglandin solution in 340 consecutive cases.
- Compared outcomes between nulliparous and multiparous women.
- Assessed the impact of prostaglandin E2 (PGE2) versus prostaglandin F2 alpha (PGF2α).
Main Results:
- Achieved a 91% success rate for pregnancy termination within 24 hours.
- Mean instillation-to-abortion intervals were significantly shorter in multiparas (12.8 hours) compared to nulliparas (17.5 hours).
- The technique was safe, with minimal side effects and no complications, and effective in women with previous cesarean sections.
Conclusions:
- Extraovular prostaglandin instillation using a double-balloon device is a highly effective and safe method for midtrimester pregnancy termination.
- The method is suitable for women with prior cesarean sections.
- Prostaglandin E2 demonstrated a faster onset of action compared to Prostaglandin F2 alpha.